Ticagrelor or clopidogrel dual antiplatelet therapy following a pharmacoinvasive strategy in ST‐segment elevation myocardial infarction

OBJECTIVES: To describe and evaluate outcomes in STEMI patients sustained on clopidogrel compared to those switched to ticagrelor following fibrinolysis. BACKGROUND: World‐wide, many STEMI patients cannot achieve timely PCI and therefore require fibrinolysis. Although comparable 30‐day and 1‐year sa...

Descripción completa

Detalles Bibliográficos
Autores principales: Welsh, Robert C., Shavadia, Jay S., Zheng, Yinggan, Tyrrell, Benjamin D., Leung, Raymond, Bainey, Kevin R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2021
Materias:
Clinical Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8571547/
https://www.ncbi.nlm.nih.gov/pubmed/34405422
http://dx.doi.org/10.1002/clc.23716

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8571547/
https://www.ncbi.nlm.nih.gov/pubmed/34405422
http://dx.doi.org/10.1002/clc.23716

Ejemplares similares